comparemela.com

Latest Breaking News On - David melles - Page 4 : comparemela.com

BetterLife Pharma to Present at the 2023 Bloom Burton & Co | The Kingston Whig Standard

Vancouver, British Columbia (Newsfile Corp. - April 24, 2023) - BetterLife Pharma (CSE: BETR), an emerging biotech company focused on the

British columbiaUnited kingdomDavid mellesBetterlife pharmaHooshmand sheshbaradaranInvestment industry regulatory organization of canadaMetro toronto convention centreNewsfile corpCanadian investor protection fundBetterlife pharma incBloom burton securities incBloom burton coHealthcare investor conferenceMetro toronto conventionWednesday aprilToronto convention centre

BetterLife s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

VANCOUVER, British Columbia, March 29, 2023 BetterLife Pharma Inc. , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental. | March 29, 2023

United kingdomUnited statesBritish columbiaDavid mellesAhmad doroudianBetterlife pharmaJohnd mccorvy medical college of wisconsinDrug discovery developmentDrug discovery development onArgel aguilar valles carleton universityBetterlife pharma incQlife pharmaDrug discoveryCalifornia san diegoArgel aguilar vallesCarleton university

BetterLife Announces Engagement of Bloom Burton Securities

VANCOUVER, British Columbia, Jan. 26, 2023 (GLOBE NEWSWIRE) BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:.

United statesFrance generalUnited kingdomBritish columbiaSan diegoAhmad doroudianDavid mellesBetterlife pharmaFederation of european neuroscience societiesBetterlife pharma incBloom burton securities incArgel aguilar valles carleton universityJohnd mccorvy medical college of wisconsinCanadian association for neuroscienceConference of society biological psychiatryMeeting of the american college neuropsychopharmacology

BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, Arizona

VANCOUVER, British Columbia - BetterLife Pharma Inc. , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, announced that. | December 5, 2022

United statesUnited kingdomBritish columbiaAhmad doroudianDavid mellesBetterlife pharmaBetterlife pharma incDepartment of neuroscienceCarleton universityQlife pharmaLysergic acid diethylamideNews publishingBetterlife pharma inc stock exchangePress releaseNnounced betrf ca08772p2026

BetterLife and Collaborators to Submit Key Joint Research

VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:.

United statesUnited kingdomBritish columbiaAhmad doroudianDavid mellesBetterlife pharmaBetterlife pharma incArgel aguilar valles carleton universityJohnd mccorvy medical college of wisconsinQlife pharmaCalifornia san diegoArgel aguilar vallesCarleton universityMedical collegeInvestor relationsCanadian stock exchange betr cn

vimarsana © 2020. All Rights Reserved.